What is Thesis?
Thesis operates as the world's first personalized brain supplement brand, addressing the unique cognitive demands of individuals. The company offers nootropics as a stimulant alternative, aiming to provide benefits such as increased focus, creativity, energy, and memory without the adverse effects of traditional stimulants. Leveraging the world's largest dataset on nootropic efficacy and advised by neuroscientists from prestigious institutions like Yale, Penn, and MIT, Thesis delivers its cognitive solutions in capsule form. This data-driven, science-backed approach positions Thesis as a leader in the burgeoning personalized wellness market.
How much funding has Thesis raised?
Thesis has raised a total of $8.4M across 1 funding round:
Series A
$8.4M
Series A (2023): $8.4M with participation from Unilever Ventures, Alive.vc, REDO Ventures, and Break Trail Ventures
Key Investors in Thesis
Unilever Ventures
Unilever Ventures is an investment firm focused on fostering brand growth and recognition for its portfolio companies, based in London, England.
REDO Ventures
REDO Ventures partners with early-stage entrepreneurs to build transformational B2C companies, emphasizing support for founders disrupting consumer technology sectors with unique approaches.
Break Trail Ventures
Break Trail Ventures is an early-stage venture fund that supports entrepreneurs addressing significant industry challenges by prioritizing customer needs and fostering innovation.
What's next for Thesis?
The substantial enterprise-level funding, particularly the recent major strategic investment, indicates that Thesis is likely in a scaling phase, aiming to expand its market reach and further develop its product offerings. This capital infusion will enable the company to enhance its data infrastructure, broaden its research initiatives, and potentially explore new product lines or delivery methods. The strategic nature of the recent investment suggests a focus on market penetration and strengthening its competitive advantage in the personalized nootropics sector. Thesis is poised to further solidify its position as a key player in the cognitive enhancement industry.
See full Thesis company page
